Skip to content

Nuvation Bio NUVB Earnings yield

Earnings yield at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
5.9%+1.6pp
Pfizer logo
PfizerPFE
6.8%
Nuvalent, Inc. logo
Nuvalent, Inc.NUVL
-5.6%-0.3pp
Immunome logo
ImmunomeIMNM
-9.1%-3.9pp
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
-14.2%-3.3pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-13.6%-5.7pp

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Calculated from Nuvation Bio’s reported figures.

Based on trailing twelve months.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's earnings yield?
Nuvation Bio (NUVB) reported earnings yield of -9.8% in Q1 2026.
How has Nuvation Bio's earnings yield changed year-over-year?
Nuvation Bio's earnings yield increased by 90.4% year-over-year, from -101.7% to -9.8%.
What is the long-term trend for Nuvation Bio's earnings yield?
Over 5 years (2020 to 2025), Nuvation Bio's earnings yield has grown at a 23.2% compound annual growth rate (CAGR), from -2.3% to -6.7%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.